Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Oper Orthop Traumatol ; 32(1): 58-72, 2020 Feb.
Article in German | MEDLINE | ID: mdl-31243472

ABSTRACT

OBJECTIVE: Restoration of a painless, weight-bearing extremity with a modular knee arthrodesis system based on a cementless modular revision stem for rotationally stable, diaphyseal anchorage. INDICATIONS: Severe bone loss and compromised soft tissue after failed total knee arthroplasty, two-stage revisions and non-reconstructible knee extensor mechanism deficiency. CONTRAINDICATIONS: Extensive osteolysis preventing diaphyseal anchorage of the prosthesis. Contralateral arthrodesis of the knee joint and/or ipsilateral arthrodesis of the hip joint and contralateral lower extremity amputation. SURGICAL TECHNIQUE: In revision cases, removal of the total knee arthroplasty, spacer, the bone cement and all intramedullary granulation tissue. Reaming the medullary cavity with intramedullary reamers to cortical contact. Restoring leg length and rotation with trial implants. After implantation of the femoral and tibial stems, placing and tensioning of the rotationally aligned coupling elements. POSTOPERATIVE MANAGEMENT: Mobilization on two forearm crutches from postoperative day 1. Removal of the Redon drains after 48 h. Partial weight bearing of 20 kg for 6 weeks postoperatively. If plain radiographs show unchanged seating of the prosthesis after 6 weeks, loading can be increased by 10 kg per week until full weight bearing is achieved. RESULTS: Between 2007 and 2012 clinical data were collected and analyzed retrospectively. A total of 27 patients had been treated within a two-stage exchange procedure with implantation of a modular intramedullary arthodesis nail TITAN (KAM-TITAN). The mean follow-up was 30.9 ± 12.0 months. A functional evaluation was performed using the Oxford Knee Score (OKS). The analyzed patients showed a mean score of 39.2 ± 8.3. To determine the pain level the Visual Analog Scale (VAS) for pain was used and showed a mean score of 2.9 ± 1.3. The rate of definitely free of infection (using Laffer criteria) at last follow-up was 85.2%.


Subject(s)
Arthrodesis , Arthroplasty, Replacement, Knee , Arthrodesis/methods , Arthroplasty, Replacement, Knee/methods , Humans , Reoperation , Retrospective Studies , Treatment Outcome
2.
Arch Orthop Trauma Surg ; 140(2): 263-273, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31820093

ABSTRACT

INTRODUCTION: Severe acetabular bone loss, both with or without pelvic discontinuity, remains a challenge in revision total hip arthroplasty (RTHA). The goal of our study was to evaluate the mid-term results for consecutive patients with Paprosky III acetabular bone loss with or without pelvic discontinuity who needed RTHA with custom-made acetabular implants and to compare the results to those of other studies. MATERIALS AND METHODS: Sixty-eight (68) patients with severe acetabular bone loss (Paprosky Type IIIa and IIIb), who required RTHA, were included in our study. All prostheses were constructed on the basis of thin-layer computed tomography (CT) scans of the pelvis. The visual analogue scale (VAS), Harrison hip score (HHS), and clinical and radiographic follow-up assessments were used to evaluate the outcome. RESULTS: The average follow-up time was 43 months (range 1-120 months). Implant survival at last follow-up was 75% (51 of 68). Kaplan-Meier survival analysis, with explantation as the endpoint, revealed survival rates of 82.7% (3 years) and 77% (5 years). Patients with revision of the acetabular component only had a significant higher survival rate (p 0.012). Overall revision rate was 36.7%. Reinfection rate was 34.4%. Complications included 15 (22%) periprosthetic joint infections (PJI), 7 dislocations (10.2%), and 2 aseptic loosenings (2.9%). Mean VAS at last follow-up was 1.45 compared to 3.2 preoperatively, while mean HHS improved from 21.1 points preoperatively to 61 at last follow-up. The change in both scores was thus significant (p < 0.001). CONCLUSION: Defect reconstruction with custom-made modular acetabular implants can be a good, nevertheless expensive, treatment option with clinically and radiologically satisfying results in comparison to recent studies in the literature. Nevertheless, high postoperative complication rates, especially in terms of PJI, remain a challenge.


Subject(s)
Acetabulum/surgery , Arthroplasty, Replacement, Hip , Hip Prosthesis , Reoperation , Adult , Aged , Aged, 80 and over , Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Hip/instrumentation , Arthroplasty, Replacement, Hip/mortality , Bone Diseases , Humans , Middle Aged , Postoperative Complications/epidemiology , Reoperation/adverse effects , Reoperation/instrumentation , Reoperation/mortality , Retrospective Studies
3.
Infection ; 47(2): 301-305, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30128751

ABSTRACT

Musculoskeletal hydatidosis is a rare but severe disease in central Europe. This case report presents the incidental finding of an osseous hydatidosis after cementless revision total hip arthroplasty in a patient without a preoperative history of hydatidosis or any clinical symptoms. Revision total hip arthroplasty had been necessary due to a septic osteonecrosis of the femoral head 2 years after osteosynthesis of a traumatic proximal femur fracture with a sliding hip screw. The positive sample was taken out of the greater trochanter in the area of the possible former entry point for the lag screw, which was macroscopic inconspicuous. Sero-analysis could afterwards confirm the suspected diagnosis. Postoperative chemotherapy with albendazole was performed for 6 months. A full-body MRI did not reveal any further cysts. This case demonstrates a possible impact of migration on the expected pathogens in revision arthroplasty. This demonstrates that in revision arthroplasty, an infection with this parasite also has to be taken into account, if the patients come from an area endemic for hydatidosis.


Subject(s)
Albendazole/therapeutic use , Anticestodal Agents/therapeutic use , Arthroplasty, Replacement, Hip , Bone Diseases/diagnosis , Echinococcosis/diagnosis , Reoperation , Adolescent , Algeria , Bone Diseases/parasitology , Bone Diseases/surgery , Echinococcosis/parasitology , Echinococcosis/surgery , Femur/injuries , Femur/parasitology , Germany , Humans , Male , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...